Atlas Trials

The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia

Clinical trial NCT05322031 · COMPLETED

Trial details

NCT number
NCT05322031
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaMyelin DegenerationCognition Disorder
Start date
2022-08-01
Primary completion
2024-08-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.